Integrative analysis of RUNX1 downstream pathways and target genes

Joëlle Michaud^1,2,9 , Ken M Simpson³ , Robert Escher^1,10 , Karine Buchet-Poyau^4,11,12 , Tim Beissbarth^3,13 , Catherine Carmichael^1,2 , Matthew E Ritchie³ , Frédéric Schütz^2,3 , Ping Cannon¹ , Marjorie Liu⁵ , Xiaofeng Shen⁶ , Yoshiaki Ito⁷ , Wendy H Raskind⁸ , Marshall S Horwitz⁸ , Motomi Osato⁷ , David R Turner⁶ , Terence P Speed³ , Maria Kavallaris⁵ , Gordon K Smyth³ and Hamish S Scott^1,14,15

¹  Molecular Medicine Division, The Walter and Eliza Hall Institute of Medical Research, Parkville 3050, Victoria, Australia

²  Department of Medical Biology, The University of Melbourne, 3050 Parkville, Victoria, Australia

³  Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville 3050, Victoria, Australia

⁴  Division of Medical Genetics, University of Geneva Medical School, 1211 Geneva, Switzerland

⁵  Experimental Therapeutics Program, Children's Cancer Institute Australia for Medical Research, 2031 NSW, Australia

⁶  Department of Hematology and Genetic Pathology, School of Medicine, Flinders University, 5001 South Australia, Australia

⁷  Molecular and Cell Biology, National University of Singapore, 117543 Singapore

⁸  Division of Medical Genetics, University of Washington, Seattle, USA

⁹  Center for Integrative Genomics, University of Lausanne, Switzerland

¹⁰  Internal Medicine, University Hospital, Berne, Switzerland

¹¹  Université de Lyon, Lyon, F-69008, France; Université Lyon 1, Domaine Rockfeller, Lyon, F-69008, France

¹²  CNRS UMR 5201, Laboratoire de Génétique Moléculaire, Signalisation et Cancer, Lyon, F-69008, France

¹³  Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany

¹⁴  Division of Molecular Pathology, the Institute of Medical and Veterinary Science and The Hanson Institute, Box 14 Rundle Mall Post Office, Adelaide, SA 5000, Australia

¹⁵  The School of Medicine the University of Adelaide, SA, 5005, Australia